S&P 500   5,105.34 (+0.18%)
DOW   38,916.63 (-0.20%)
QQQ   440.72 (+0.39%)
AAPL   180.10 (-0.36%)
MSFT   413.87 (+0.06%)
META   498.27 (+1.66%)
GOOGL   138.04 (-0.30%)
AMZN   176.71 (-0.03%)
TSLA   199.52 (-1.17%)
NVDA   802.95 (+1.50%)
NIO   5.70 (-0.87%)
AMD   198.19 (+2.94%)
BABA   74.94 (+1.23%)
T   16.88 (-0.30%)
F   12.36 (-0.64%)
MU   94.28 (+4.05%)
CGC   3.22 (-2.13%)
GE   157.64 (+0.48%)
DIS   111.50 (-0.07%)
AMC   4.28 (-0.93%)
PFE   26.61 (+0.19%)
PYPL   61.00 (+1.09%)
XOM   105.87 (+1.29%)
S&P 500   5,105.34 (+0.18%)
DOW   38,916.63 (-0.20%)
QQQ   440.72 (+0.39%)
AAPL   180.10 (-0.36%)
MSFT   413.87 (+0.06%)
META   498.27 (+1.66%)
GOOGL   138.04 (-0.30%)
AMZN   176.71 (-0.03%)
TSLA   199.52 (-1.17%)
NVDA   802.95 (+1.50%)
NIO   5.70 (-0.87%)
AMD   198.19 (+2.94%)
BABA   74.94 (+1.23%)
T   16.88 (-0.30%)
F   12.36 (-0.64%)
MU   94.28 (+4.05%)
CGC   3.22 (-2.13%)
GE   157.64 (+0.48%)
DIS   111.50 (-0.07%)
AMC   4.28 (-0.93%)
PFE   26.61 (+0.19%)
PYPL   61.00 (+1.09%)
XOM   105.87 (+1.29%)
S&P 500   5,105.34 (+0.18%)
DOW   38,916.63 (-0.20%)
QQQ   440.72 (+0.39%)
AAPL   180.10 (-0.36%)
MSFT   413.87 (+0.06%)
META   498.27 (+1.66%)
GOOGL   138.04 (-0.30%)
AMZN   176.71 (-0.03%)
TSLA   199.52 (-1.17%)
NVDA   802.95 (+1.50%)
NIO   5.70 (-0.87%)
AMD   198.19 (+2.94%)
BABA   74.94 (+1.23%)
T   16.88 (-0.30%)
F   12.36 (-0.64%)
MU   94.28 (+4.05%)
CGC   3.22 (-2.13%)
GE   157.64 (+0.48%)
DIS   111.50 (-0.07%)
AMC   4.28 (-0.93%)
PFE   26.61 (+0.19%)
PYPL   61.00 (+1.09%)
XOM   105.87 (+1.29%)
S&P 500   5,105.34 (+0.18%)
DOW   38,916.63 (-0.20%)
QQQ   440.72 (+0.39%)
AAPL   180.10 (-0.36%)
MSFT   413.87 (+0.06%)
META   498.27 (+1.66%)
GOOGL   138.04 (-0.30%)
AMZN   176.71 (-0.03%)
TSLA   199.52 (-1.17%)
NVDA   802.95 (+1.50%)
NIO   5.70 (-0.87%)
AMD   198.19 (+2.94%)
BABA   74.94 (+1.23%)
T   16.88 (-0.30%)
F   12.36 (-0.64%)
MU   94.28 (+4.05%)
CGC   3.22 (-2.13%)
GE   157.64 (+0.48%)
DIS   111.50 (-0.07%)
AMC   4.28 (-0.93%)
PFE   26.61 (+0.19%)
PYPL   61.00 (+1.09%)
XOM   105.87 (+1.29%)
OTCMKTS:CLPBY

Coloplast A/S (CLPBY) Stock Price, News & Analysis

$13.39
+0.18 (+1.36%)
(As of 02/29/2024 ET)
Today's Range
$13.29
$13.39
50-Day Range
$11.24
$13.45
52-Week Range
$9.90
$14.77
Volume
75,111 shs
Average Volume
234,823 shs
Market Capitalization
N/A
P/E Ratio
40.03
Dividend Yield
N/A
Price Target
N/A

CLPBY stock logo

About Coloplast A/S Stock (OTCMKTS:CLPBY)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

CLPBY Stock Price History

CLPBY Stock News Headlines

Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Coloplast A/S (CLPBY)
Coloplast A/S - Allocation of Share Options
Coloplast A/S - Allocation of Share Options
Coloplast A/S - Interim Financial Report, Q1 2023/24
The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
Coloplast A/S ADR
Coloplast A/S goes ex-dividend tomorrow
Coloplast A/S - Notice of Annual General Meeting 2023
Major shareholder notification
CLPBY Coloplast A/S
Short Volatility Alert: Coloplast
See More Headlines
Receive CLPBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 12/22 Dividend
12/08/2023
Dividend Payable
12/22/2023
Last Earnings
2/09/2024
Today
3/01/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:CLPBY
Previous Symbol
NASDAQ:CLPBY
Fax
N/A
Employees
15,751
Year Founded
1954

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.58 billion

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Kristian Villumsen (Age 54)
    President & CEO
    Comp: $2.53M
  • Mr. Anders Lonning-Skovgaard (Age 52)
    Executive VP & CFO
    Comp: $1.3M
  • Mr. Allan Rasmussen (Age 57)
    Executive Vice President of Global Operations
    Comp: $1.14M
  • Mr. Nicolai Buhl Andersen (Age 55)
    Executive Vice President of Innovation
    Comp: $1.1M
  • Mr. Paul Marcun (Age 57)
    Executive Vice President of Growth
    Comp: $1.32M
  • Mr. Thomas Barfod (Age 54)
    Senior Controller & Employees Representative Director
    Comp: $65.04k
  • Ellen Bjurgert
    Vice President of Investor Relations
  • Dennis Kaysen
    Director of Corporate Communications
  • Dorthe Ronnau (Age 58)
    Senior Vice President of People & Culture
  • Mr. Alain Morvan
    Senior Vice President of Sales Europe














CLPBY Stock Analysis - Frequently Asked Questions

Should I buy or sell Coloplast A/S stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Coloplast A/S in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CLPBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLPBY, but not buy additional shares or sell existing shares.
View CLPBY analyst ratings
or view top-rated stocks.

How have CLPBY shares performed in 2024?

Coloplast A/S's stock was trading at $11.53 at the start of the year. Since then, CLPBY stock has increased by 16.1% and is now trading at $13.39.
View the best growth stocks for 2024 here
.

Are investors shorting Coloplast A/S?

Coloplast A/S saw a drop in short interest in the month of February. As of February 15th, there was short interest totaling 26,700 shares, a drop of 84.5% from the January 31st total of 172,700 shares. Based on an average daily volume of 384,400 shares, the days-to-cover ratio is presently 0.1 days.
View Coloplast A/S's Short Interest
.

How were Coloplast A/S's earnings last quarter?

Coloplast A/S (OTCMKTS:CLPBY) announced its quarterly earnings data on Friday, February, 9th. The company reported $0.08 EPS for the quarter, meeting the consensus estimate of $0.08. The company earned $953.60 million during the quarter.

How often does Coloplast A/S pay dividends? What is the dividend yield for Coloplast A/S?

Coloplast A/S declared a dividend on Friday, November 17th. Investors of record on Monday, December 11th will be paid a dividend of $0.1498 per share on Friday, December 22nd. The ex-dividend date of this dividend is Friday, December 8th. This is an increase from the stock's previous dividend of $0.05.
Read our dividend analysis for CLPBY
.

How do I buy shares of Coloplast A/S?

Shares of CLPBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CLPBY) was last updated on 3/1/2024 by MarketBeat.com Staff